BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20924143)

  • 1. Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab.
    Melichar B; Krcmová L; Kalábová H; Holecková P; Kasparová M; Plísek J; Hyspler R; Studentová H; Solichová D
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(4):222-6. PubMed ID: 20924143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin.
    Melichar B; Kalábová H; Krcmová L; Kasparová M; Malírová E; Melicharová K; Pecka M; Hyspler R; Solichová D
    Anticancer Res; 2009 Nov; 29(11):4813-20. PubMed ID: 20032440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha-tocopherol, retinol and neopterin during paclitaxel/carboplatin chemotherapy.
    Melichar B; Kalábová H; Krcmová L; Urbánek L; Hyspler R; Malírova E; Solichová D
    Anticancer Res; 2007; 27(6C):4397-401. PubMed ID: 18214051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours.
    McMillan DC; Talwar D; Sattar N; Underwood M; O'Reilly DS; McArdle C
    Clin Nutr; 2002 Apr; 21(2):161-4. PubMed ID: 12056790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial.
    Faure H; Preziosi P; Roussel AM; Bertrais S; Galan P; Hercberg S; Favier A
    Eur J Clin Nutr; 2006 Jun; 60(6):706-17. PubMed ID: 16391586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of serum retinol, serum alpha-tocopherol, and urinary neopterin in patients with head and neck carcinoma treated with external beam radiation.
    Holečková P; Krčmová L; Kalábová H; Kašparová M; Plíšek J; Pála M; Vítek P; Solichová D; Zezulová M; Studentová H; Melichar B
    Int J Vitam Nutr Res; 2012 Apr; 82(2):77-84. PubMed ID: 23065832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers.
    Malila N; Virtamo J; Virtanen M; Pietinen P; Albanes D; Teppo L
    Eur J Clin Nutr; 2002 Jul; 56(7):615-21. PubMed ID: 12080400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer.
    Boccia RV; Cosgriff TM; Headley DL; Badarinath S; Dakhil SR
    Clin Colorectal Cancer; 2010 Apr; 9(2):102-7. PubMed ID: 20378504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer.
    Yen LC; Yeh YS; Chen CW; Wang HM; Tsai HL; Lu CY; Chang YT; Chu KS; Lin SR; Wang JY
    Clin Cancer Res; 2009 Jul; 15(13):4508-13. PubMed ID: 19549774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors contributing to gender differences in serum retinol and alpha-tocopherol in infertile couples.
    Al-Azemi MK; Omu AE; Fatinikun T; Mannazhath N; Abraham S
    Reprod Biomed Online; 2009 Oct; 19(4):583-90. PubMed ID: 19909602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
    Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
    JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.
    Lévi F; Karaboué A; Gorden L; Innominato PF; Saffroy R; Giacchetti S; Hauteville D; Guettier C; Adam R; Bouchahda M
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):339-48. PubMed ID: 20401611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation.
    Dvorák J; Melichar B; Hyspler R; Krcmová L; Urbánek L; Kalábová H; Kasparová M; Solichová D
    Med Oncol; 2010 Sep; 27(3):690-6. PubMed ID: 19629763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum level of retinol and α-tocopherol affords protection against oral cancer in a multiethnic population.
    Athirajan V; Razak IA; Thurairajah N; Ghani WM; Ching HN; Yang YH; Peng KN; Abdul Rahman ZA; Mustafa WM; Abraham MT; Kiong TK; Mun YK; Jalil N; Zain RB
    Asian Pac J Cancer Prev; 2014; 15(19):8183-9. PubMed ID: 25339003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a liquid chromatography method for the simultaneous determination of alpha-tocopherol, retinol and retinyl esters in human serum using a monolithic column for the monitoring of anticancer therapy side effects.
    Urbánek L; Krcmová L; Solichová D; Melichar B; Opletalová V; Solich P
    J Sep Sci; 2006 Nov; 29(16):2485-93. PubMed ID: 17154129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum antioxidant vitamins A, E, and C and lipid profiles in priest subjects at the Priest Hospital.
    Viroonudomphol D; Mahaisiriyodom A; Mingkhawn R; Sadomthian P; Korchasri N; Jittngamkhum S; Sangcakul A
    Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():246-53. PubMed ID: 16438218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
    Cunningham D; Humblet Y; Siena S; Khayat D; Bleiberg H; Santoro A; Bets D; Mueser M; Harstrick A; Verslype C; Chau I; Van Cutsem E
    N Engl J Med; 2004 Jul; 351(4):337-45. PubMed ID: 15269313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal-neonatal retinol and alpha-tocopherol serum concentrations in Greeks and Albanians.
    Schulpis KH; Michalakakou K; Gavrili S; Karikas GA; Lazaropoulou C; Vlachos G; Bakoula C; Papassotiriou I
    Acta Paediatr; 2004 Aug; 93(8):1075-80. PubMed ID: 15456199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experience of the treatment with cetuximab for unresectable advanced colorectal cancer].
    Yokomizo H; Yoshimatsu K; Osawa G; Matsumoto A; Otani T; Yano Y; Itagaki H; Fujimoto T; Umehara A; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2249-51. PubMed ID: 21224537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate serum levels of retinol, alpha-tocopherol, 25 hydroxyvitamin D3 and 24,25 dihydroxyvitamin D3 levels in healthy Spanish adults: simultaneous assessment by HPLC.
    Mata-Granados JM; Luque de Castro MD; Quesada Gomez JM
    Clin Biochem; 2008 Jun; 41(9):676-80. PubMed ID: 18313404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.